CCDC112 anticorps (AA 71-120)
Aperçu rapide pour CCDC112 anticorps (AA 71-120) (ABIN205068)
Antigène
Voir toutes CCDC112 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 71-120
-
Specificité
- Human CCDC112
-
Homologie
- Percent identity by BLAST analysis: Human, Monkey (100%) Mouse (85%).
-
Purification
- Protein A purified
-
Immunogène
-
Synthetic peptide located between aa71-120 of human CCDC112 (Q6A334, NP_001035530). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Marmoset, Dog, Bovine, Bat (100%), Galago, Elephant, Rabbit, Horse (92%), Mouse (85%), Rat (78%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P, WB (1.25 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- CCDC112 (Coiled-Coil Domain Containing 112 (CCDC112))
-
Autre désignation
- CCDC112 / MBC1
-
Sujet
-
Name/Gene ID: CCDC112
Synonyms: CCDC112, Mutated in bladder cancer 1, MBC1 -
ID gène
- 153733
-
NCBI Accession
- NP_001035530
-
UniProt
- Q8NEF3
Antigène
-